TRUTAKNA is the first and only available therapy that binds both B-cell activating factor (BAFF) and A PRoliferation-Inducing Ligand (APRIL), addressing the immunological drivers at the source of IgA ...
Babies born in the U.S. between July 2 and Dec. 31, 2026, will receive a "first-of-its-kind" commemorative Social Security card.
Official FDA minutes confirm the previously announced End-of-Phase 2 meeting outcomes and provide additional detail on the planned Phase 3 protocol - ...
Official FDA minutes confirm the previously announced End-of-Phase 2 meeting outcomes and provide additional detail on the planned Phase 3 protocol - - FDA agreed that a single pivotal Phase 3 trial ...
Developers are increasingly relying on large language models (LLMs) for everyday computing tasks such as fixing bugs, ...
Vanta reports four risk treatment strategies-mitigate, accept, transfer, and avoid-to effectively manage threats, enhancing ...
Elson Nash, an education and social impact leader, Senior Fellow at Blue Meridian Partners, and By All Means Senior Fellow at ...
Support vector regression can predict numeric values effectively, and this article shows how to implement and train a kernel SVR model in C# using stochastic sub-gradient descent.
Starting Wednesday, millions of Medicare-qualifying adults will have access to popular medications for weight loss at deep ...
Microsoft plans to cut under 2.5% of its 220,000-person workforce next week, targeting sales, consulting, and Xbox roles amid ...
Taysha Gene Therapies (TSHA) remains a Buy on strong TSHA-102 Rett data, FDA-aligned pivotal path, and cash to 2028—read the ...
Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious underserved diseases, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results